Viewing Study NCT00717366

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 4:03 PM

Ignite Modification Date: 2026-01-01 @ 3:39 PM

Study NCT ID: NCT00717366

Status: COMPLETED

Last Update Posted: 2017-09-08

First Post: 2008-07-16

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on Hemodialysis

Sponsor: Hoffmann-La Roche

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module